Pfizer-partnered cancer startup goes public in $143M IPO
October 08, 2021 at 12:24 PM EDT
Pyxis Oncology, the Longwood Fund spinout focused on solid tumors that scored a licensing deal with Pfizer Inc. (NYSE: PFE) earlier this year, has gone public, raising $143 million in an IPO.
